Follow on Google News News By Tag Industry News * Pharmaceutical * More Industries... News By Place Country(s) Industry News
Follow on Google News | Auxiliis-Pharma paediatric clinical research services lines up with Svabhegy children hospitalAuxiliis-Pharma CRO aligns with Svabhegy Paediatric Hospital, the first specialized paediatric CROs (EU) focusing on paediatric clinical trials for orphan drugs and special drug development for children. The new company is called Auxiliis-Pharma PCRS
By: Erik Hamminga Through the agreement Auxiliis-Pharma PCRS offers clients full service contracts regarding the conduct of paediatric clinical trials. Svabhegy Paediatrics is setting up a strong collaboration network in Hungary together with several other children hospitals. Dr. Wouter Wijker, CEO of the company has over 25 years of expertise in clinical research and as statistician starting as CEO at BWO in 1994 in the Netherlands. Dr. Otto Skoran, former owner and CEO of aHungarian market-leader CRO has extensive expertise in clinical research since 1987. Currently he is CEO of Svabhegy Pediatrics. Auxiliis Pharma is a Contract Research Organisation (CRO) consisting of three business units: Auxiliis-Pharma PCRS dedicated to paediatric clinical trials, Auxiliis-Pharma Biometrics and Auxiliis-Pharma Pharmacovigilance. Auxiliis-Pharma offers a comprehensive package of research services for the pharmaceutical industry. Working closely with our clients, we are committed to providing customized services that meet the highest standards of quality on time and within budget. Svabhegy Paediatrics is a privately owned children’s hospital located in Budapest with thorough experience in clinical trials with medicines specially designed or altered according the EMA directive for children. Svabhegy Paediatrics has over 30 paediatricians taking care of childrens healthcare at the highest level of expertise and the highest ethical standards. E. Hamminga Director Marketing & Business Development Auxiliis-Pharma PCRS +31 6 188 356 08 (NL) Erik.hamminga@ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|